I (like many of you here) obviously believe that RAP is onto something with this whole 'algorithmic detection of cough sound spectrum' stuff.
But I'm starting to find it extremely odd that RAP management seems to be capable of delivering only 2 things -
1. Excellent results in the largely symbolic Australian studies with no consequences
2. Delays and failures in US studies that have actual repercussions for the company
Is it just me?
- Forums
- ASX - By Stock
- RAP
- Ann: Voluntary Suspension
Ann: Voluntary Suspension, page-90
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 401 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)